Redmile Group’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-8,930
Closed -$208K 86
2018
Q2
$208K Buy
+8,930
New +$185K 0.01% 77
2015
Q3
Sell
-384,506
Closed -$85.4M 60
2015
Q2
$85.4M Buy
384,506
+115,987
+43% +$25.7M 7% 3
2015
Q1
$53.3M Sell
268,519
-69,958
-21% -$12.4M 4.79% 4
2014
Q4
$48.4M Buy
338,477
+5,910
+2% +$795K 5.27% 3
2014
Q3
$43.6M Buy
332,567
+104,737
+46% +$12.5M 5.04% 2
2014
Q2
$28.7M Sell
227,830
-69,306
-23% -$8.84M 3.49% 11
2014
Q1
$39.2M Buy
+297,136
New +$40.6M 4.68% 4

Other funds holding BHC

Redmile Group's BHC Position: Q3 2018 in Review

Redmile Group sold out of Bausch Health (BHC) in Q3 2018, closing a stake of 8,930 shares — an estimated $208K sold.

Redmile Group first reported a position in BHC in Q1 2014 and held it in 7 quarters. The position peaked at $85.4M in Q2 2015. 332 funds tracked by Wall St. Rank hold BHC as of Q3 2018.

  • Redmile Group reported no remaining Bausch Health position as of Q3 2018 after selling out during the quarter.
  • Redmile Group sold 8,930 Bausch Health shares in Q3 2018, an estimated $208K.
  • Redmile Group first reported a position in Bausch Health in Q1 2014 and held it in 7 quarters.
  • Redmile Group's Bausch Health position peaked at $85.4M in Q2 2015.
  • 332 funds tracked by Wall St. Rank held Bausch Health as of Q3 2018.

Based on Redmile Group's 13F filing for Q3 2018, filed 14 Nov 2018.